University of Cincinnati hematology researcher to study bone complications in sickle cell disease
Grant and Award Announcement
Updates every hour. Last Updated: 24-Oct-2026 23:17 ET (25-Oct-2026 03:17 GMT/UTC)
University of Cincinnati hematology researcher Jahnavi Gollamudi, MD, has received new grant funding to study how inflammation predicts bone complications in people with sickle cell disease, offering new hope for treatment.
JMIR Publications released six feature News and Perspectives articles this week, covering everything in digital health from patient simulator robots to a novel mobile app for patients to store their digital health records.
Matthew G. Nayor, MD, MPH, associate professor medicine at Boston University Chobanian & Avedisian School of Medicine, has been named medical director of the Framingham Heart Study (FHS). In this newly created position, Nayor will initially oversee and enhance the capture and adjudication of clinical events, including cardiovascular events, stroke, other major medical events, and cause-of-death determinations. In addition, he will participate in clinical examinations and provide oversight of findings that require referrals or alerts for FHS participants.